Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphoma.
Ozer, H
Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphoma. [electronic resource] - Investigational new drugs 1987 - S27-33 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0167-6997
10.1007/BF00207260 doi
Adult
Aged
Anemia--chemically induced
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Clinical Trials as Topic
Cyclophosphamide--adverse effects
Female
Humans
Interferon Type I--adverse effects
Lymphoma, Non-Hodgkin--therapy
Male
Middle Aged
Thrombocytopenia--chemically induced
Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphoma. [electronic resource] - Investigational new drugs 1987 - S27-33 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0167-6997
10.1007/BF00207260 doi
Adult
Aged
Anemia--chemically induced
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Clinical Trials as Topic
Cyclophosphamide--adverse effects
Female
Humans
Interferon Type I--adverse effects
Lymphoma, Non-Hodgkin--therapy
Male
Middle Aged
Thrombocytopenia--chemically induced